Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 10 years or older~* Both sex (male or female)~* Allogeneic transplant patient for hematologic malignancy or aplastic anemia~Exclusion Criteria:~* Previous intolerance to acyclovir~* Patients who are unavailable for follow-up~* Patients in whom drug compliance may be a problem~* Evidence of active VZV infection~* VZV infection in the initial 1 month after transplant~* Pregnant women, lactating women, or those not using adequate contraception~* Creatinine \> 3.0 mg/dl.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).